|
NCL expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.78034999999133E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.810500E-04 |
| Normal-vs-Stage2 |
1.021610E-02 |
| Normal-vs-Stage3 |
1.5321899999976E-05 |
| Normal-vs-Stage4 |
5.84780000000285E-05 |
| Stage1-vs-Stage2 |
7.354600E-01 |
| Stage1-vs-Stage3 |
9.910200E-02 |
| Stage1-vs-Stage4 |
2.149400E-01 |
| Stage2-vs-Stage3 |
4.399000E-01 |
| Stage2-vs-Stage4 |
6.273600E-01 |
| Stage3-vs-Stage4 |
7.309400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.16459999999863E-05 |
| Normal-vs-AfricanAmerican |
2.426400E-01 |
| Normal-vs-Asian |
3.079800E-02 |
| Caucasian-vs-AfricanAmerican |
2.369200E-01 |
| Caucasian-vs-Asian |
3.048200E-01 |
| AfricanAmerican-vs-Asian |
7.049600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.01010000000701E-05 |
| Normal-vs-Female |
5.53220000000243E-05 |
| Male-vs-Female |
4.579000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.639500E-04 |
| Normal-vs-Age(41-60Yrs) |
3.66390000000605E-05 |
| Normal-vs-Age(61-80Yrs) |
6.14329999999441E-05 |
| Normal-vs-Age(81-100Yrs) |
1.282430E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.396000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.950400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.199200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.708800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.782200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.002000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.116810E-01 |
| Classical-VS-Follicular |
7.014600E-04 |
| Classical-VS-Other |
2.030800E-01 |
| Classical-VS-Normal |
1.376170E-02 |
| Tall-VS-Follicular |
4.307400E-01 |
| Tall-VS-Other |
7.160800E-01 |
| Tall-VS-Normal |
2.800700E-03 |
| Follicular-VS-Other |
9.405200E-01 |
| Follicular-VS-Normal |
1.89979999998258E-06 |
| Other-VS-Normal |
2.351600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.52294999999913E-05 |
| Normal-vs-N1 |
1.74933000000044E-05 |
| N0-vs-N1 |
2.557600E-01 |
|
|
